Skip to content
OpenCapital
Get started

Collegium Pharmaceutical, Inc. COLL Cash ratio

Cash ratio at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc. INDV
0.2×-0.1×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
5.7×+0.5×
Avanos Medical logo
Avanos MedicalAVNS
0.5×-0.2×
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
1.3×+0.4×
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
0.5×+0.1×
Theravance Biopharma logo
Theravance BiopharmaTBPH
9.1×+5.6×

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0×0.0×
Current ratio1.7×+0.6×

Where this comes from

Calculated from Collegium Pharmaceutical, Inc.’s reported figures.

cash and equivalents/total current liabilities=0.7×

Based on the most recent quarter.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s cash ratio?
Collegium Pharmaceutical, Inc. (COLL) reported cash ratio of 0.7× in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s cash ratio changed year-over-year?
Collegium Pharmaceutical, Inc.'s cash ratio increased by 176.7% year-over-year, from 0.2× to 0.7×.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s cash ratio?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s cash ratio has grown at a -4.7% compound annual growth rate (CAGR), from 0.7× to 0.6×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.